Daily Archive: April 17, 2015

Bristol’s Opdivo Scores Again Against Lung Cancer

Big pharma Bristol-Myers Squibb‘s (NYSE:BMY) cancer drug Opdivo continued to shine Friday, as the company halted another clinical trial early because it had already hit its endpoint. The phase-three trial, called Checkpoint-057, compared Opdivo in...